Herzich Paul, Chief Technology Officer at Solid Biosciences Inc. ($SLDB), sold shares on the open market four times in the last 365 days, totaling about $274 thousand. His most recent sale occurred on February 18, 2026. These sales rank 7,757th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions. Herzich Paul made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | S | Common Stock | 3616 | $5.82 | 72,638.0000 | 94,417,746 | 4.74% | 0.00% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Common Stock | 7187 | $0.00 | 76,254.0000 | 94,417,746 | 10.41% | 0.01% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Restricted Stock Units | 7187 | $0.00 | 14,376.0000 | 94,417,746 | 33.33% | 0.01% |
| Feb. 4, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | S | Common Stock | 10905 | $6.44 | 69,067.0000 | 94,417,746 | 13.64% | 0.01% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Employee Stock Option (Right to Buy) | 170000 | $0.00 | 170,000.0000 | 94,417,746 | 9999.99% | 0.18% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Performance Stock Units | 54925 | $0.00 | 0.0000 | 94,417,746 | 100.00% | 0.06% |
| Feb. 2, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | S | Common Stock | 26250 | $6.44 | 79,972.0000 | 94,417,746 | 24.71% | 0.03% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Common Stock | 24675 | $0.00 | 106,222.0000 | 94,417,746 | 30.26% | 0.03% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Common Stock | 54925 | $0.00 | 81,547.0000 | 94,417,746 | 206.31% | 0.06% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Restricted Stock Units | 24675 | $0.00 | 74,025.0000 | 94,417,746 | 25.00% | 0.03% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Restricted Stock Units | 85000 | $0.00 | 85,000.0000 | 94,417,746 | 9999.99% | 0.09% |
| Dec. 3, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | S | Common Stock | 2701 | $5.11 | 26,622.0000 | 94,417,746 | 9.21% | 0.00% |
| Dec. 2, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Common Stock | 7239 | $0.00 | 29,323.0000 | 94,417,746 | 32.78% | 0.01% |
| Dec. 2, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Restricted Stock Units | 7239 | $0.00 | 7,239.0000 | 94,417,746 | 50.00% | 0.01% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Employee Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 40,816,694 | 9999.99% | 0.25% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Restricted Stock Units | 50000 | $0.00 | 50,000.0000 | 40,816,694 | 9999.99% | 0.12% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Restricted Stock Units | 7187 | $0.00 | 21,563.0000 | 40,816,694 | 25.00% | 0.02% |
| Feb. 14, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | S | Common Stock | 2688 | $3.96 | 18,388.0000 | 40,816,694 | 12.75% | 0.01% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Common Stock | 7187 | $0.00 | 21,076.0000 | 40,816,694 | 51.75% | 0.02% |
| Jan. 31, 2025 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Restricted Stock Units | 98700 | $0.00 | 98,700.0000 | 40,816,694 | 9999.99% | 0.24% |
| Dec. 2, 2024 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Common Stock | 7239 | $0.00 | 14,959.0000 | 41,443,317 | 93.77% | 0.02% |
| Dec. 2, 2024 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | M | Restricted Stock Units | 7239 | $0.00 | 14,478.0000 | 41,443,317 | 33.33% | 0.02% |
| Dec. 3, 2024 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | S | Common Stock | 2777 | $5.60 | 12,182.0000 | 41,443,317 | 18.56% | 0.01% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Restricted Stock Units | 28750 | $0.00 | 28,750.0000 | 19,884,007 | 9999.99% | 0.14% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Herzich Paul | Chief Technology Officer | A | Employee Stock Option (Right to Buy) | 57500 | $0.00 | 57,500.0000 | 19,884,007 | 9999.99% | 0.29% |